Rockefeller University - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Rockefeller University (Rockefeller) is a biomedical research university that offers graduate and postdoctoral educational programs. The university offers educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics. It conducts clinical studies in the areas of addictive diseases, auditory studies, blood disorders, cancer, immunology, neurologic and psychiatric disorders, and others. Rockefeller offers research services in chemical and structural biology, genetics and genomics, molecular and cell biology, neurosciences and behavior, immunology, virology and microbiology, medical sciences, systems physiology and human genetics, organismal biology, evolution, ethology and ecology, physical, mathematical and computational biology, stem cells, development, and regeneration and aging. The university also provides professional and financial support services. Rockefeller is headquartered in New York, the US.

Rockefeller University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rockefeller University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Rockefeller University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rockefeller University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Hemogenyx Pharma Enters into Research Agreement with Rockefeller 11
Morphotek Enters into Research Agreement with Rockefeller University 12
ContraFect Enters into Research Agreement with Rockefeller University 13
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 14
QR Pharma Enters into Research Agreement with Rockefeller University 15
Licensing Agreements 16
Frontier Biotechnologies Enters into Licensing Agreement with Rockefeller University 16
Cerevance Enters into Licensing Agreement with Rockefeller University 17
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
NeoStem Enters into Licensing Agreement with Rockefeller University for Patented Technologies 20
TaiMed Biologics Enters into Licensing Agreement with Rockefeller University 21
Lodo Therapeutics Enters into Licensing Agreement with Rockefeller University 22
Rockefeller University - Key Competitors 23
Rockefeller University - Key Employees 24
Rockefeller University - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Recent Developments 26
Government and Public Interest 26
Jul 02, 2018: Study reveals new understanding of certain psychiatric diseases 26
Jun 21, 2018: Scientists solve the case of the missing subplate, with wide implications for brain science 27
Apr 23, 2018: New method allows scientists to study how HIV persists 28
Mar 12, 2018: Molecular doorstop could be key to new tuberculosis drugs 29
Feb 27, 2018: Cure Alzheimers Fund Issued more than $15 Million in Research Grants in 2017 30
Jan 29, 2018: Uncovering the early origins of Huntingtons disease 31
Nov 02, 2017: Potential new treatment for Fragile X targets one gene to affect many 33
Jul 24, 2017: Researchers develop new method to generate human antibodies 34
Jun 09, 2017: NIH Funds NYC Center for AIDS Research 35
Mar 06, 2017: A new way to reset gene expression in cancer cells shows promise for leukemia treatment 36
Feb 24, 2017: New structural studies reveal workings of a molecular pump that ejects cancer drugs 38
Feb 03, 2017: Atomic-scale view of bacterial proteins offers path to new tuberculosis drugs 39
Product News 40
Apr 06, 2018: Small molecule from Kapoor lab is accepted as first Bridge Medicines drug candidate 40
02/06/2017: Encouraging clinical results for an antibody drug to prevent or treat HIV 41
01/17/2017: Successful antibody trial in HIV-infected individuals 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables

List of Tables
Rockefeller University, Pharmaceuticals & Healthcare, Key Facts 2
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rockefeller University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rockefeller University, Deals By Therapy Area, 2012 to YTD 2018 9
Rockefeller University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hemogenyx Pharma Enters into Research Agreement with Rockefeller 11
Morphotek Enters into Research Agreement with Rockefeller University 12
ContraFect Enters into Research Agreement with Rockefeller University 13
MabVax Therapeutics Enters into Research Agreement with Rockefeller University 14
QR Pharma Enters into Research Agreement with Rockefeller University 15
Frontier Biotechnologies Enters into Licensing Agreement with Rockefeller University 16
Cerevance Enters into Licensing Agreement with Rockefeller University 17
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
NeoStem Enters into Licensing Agreement with Rockefeller University for Patented Technologies 20
TaiMed Biologics Enters into Licensing Agreement with Rockefeller University 21
Lodo Therapeutics Enters into Licensing Agreement with Rockefeller University 22
Rockefeller University, Key Competitors 23
Rockefeller University, Key Employees 24
Rockefeller University, Joint Venture 25

List Of Figures

List of Figures
Rockefeller University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Rockefeller University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Rockefeller University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Rockefeller University - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Rockefeller University (Rockefeller) is a biomedical research university that offers graduate and postdoctoral educational programs. The university offers educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics.

USD 250 View Report

Rockefeller University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Rockefeller University (Rockefeller) is a biomedical research university that offers graduate and postdoctoral educational programs. The university offers educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics.

USD 250 View Report

Tulane University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tulane University (Tulane) is an educational service provider that provides biomedical courses and research programs. The university provides educational courses in the fields of architecture, business, law, liberal arts, medicine,

USD 250 View Report

Yonsei University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Yonsei University (Yonsei) is an educational service provider that offers training and research services. The university offers graduation programs in various areas such as applied statistics, architectural engineering, Asian studies,

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available